Contract Research Firm CMIC Joins Pharma Market With Orphan Drug, With More On The Way
This article was originally published in PharmAsia News
Executive Summary
Novartis and Novo Nordisk receive first global approvals for compounds in Japan in recent slate of approvals, along with a wave of government-subsidized orphan drugs.